|
EVT-101
|
DB05956 |
|
|
DERIVATIVE OF AKLANONIC ACID METHYL ESTER (AAME)
|
DB04624 |
|
|
N-ACETYLHISTAMINE
|
DB04622 |
|
|
2-ETHOXYETHYL (2S,3S)-4-((S)-2-BENZYL-3-OXO-4-((3AR,8R,8AS)-2-OXO-3,3A,8,8A-TETRAHYDRO-2H-INDENO[1,2-D]OXAZOL-8-YL)-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE
|
DB04623 |
|
|
Cycloleucine
|
DB04620 |
[Cycloleucine is non-metabolisable amino acid formed by cyclization of leucine. It is also a specific and reversible inhibitor of nucleic acid methylation and widely used in biochemical experiments.] |
|
Contulakin-G
|
DB05950 |
[Contulakin-G is a broad spectrum non-opioid analgesic. It is the synthetic form of a natural peptide extracted from the venom of the Conus Geographus sea snail.] |
|
[(1S)-4-[[Amino-[(2R)-2-amino-2-carboxyethyl]sulfanylmethylidene]amino]-1-carboxybutyl]azanium
|
DB04671 |
|
|
3-[(1-Amino-2-Carboxy-Ethyl)-Hydroxy-Phosphinoyl]-2-Methyl-Propionic Acid
|
DB03340 |
|
|
CoA-S-acetyl 5-bromotryptamine
|
DB03341 |
|
|
Cyclic 3',5'-thymidine monophosphate
|
DB04672 |
|
|
Staurosporine
|
DB02010 |
[An indolocarbazole that is a potent protein kinase C inhibitor which enhances cAMP-mediated responses in human neuroblastoma cells. (Biochem Biophys Res Commun 1995;214(3):1114-20)] |
|
Nattokinase
|
DB15329 |
[Nattokinase is under investigation in clinical trial NCT00749801 (Efficacy and Safety of Geneferm Nattokinase).] |
|
CXL-1020
|
DB15326 |
[CXL-1020 is under investigation in clinical trial NCT01092325 (Safety and Hemodynamic Effects and Pharmacokinetics of CXL-1020 in Patients With Stable Heart Failure).] |
|
ONO-8539
|
DB15325 |
[ONO-8539 is under investigation in clinical trial NCT01707901 (A Study of the Effect of ONO-8539 on Oesophageal Pain Hypersensitivity in Patients With Non-erosive Reflux Disease).] |
|
Ubrogepant
|
DB15328 |
[Ubrogepant is indicated for the acute (immediate) treatment of migraine with or without aura (a sensory phenomenon or visual disturbance) in adults. It was approved by the FDA on December 23, 2019.] |
|
Abivertinib
|
DB15327 |
[Abivertinib is under investigation in clinical trial NCT03300115 (Clinical Trial of the Efficacy and Safety of AC0010 in the Treatment of EGFR T790M Patients With Advanded NSCLC).] |
|
Lacutamab
|
DB15322 |
[Lacutamab is under investigation in clinical trial NCT02593045 (Study of IPH4102 in Patients With Relapsed/Refractory Cutaneous T-cell Lymphomas (CTCL)).] |
|
Tefinostat
|
DB15321 |
[Tefinostat is under investigation in clinical trial NCT02759601 (Dose Escalation Trial of Tefinostat for Cancer Associated Inflamation in Hepatocellular Carcinoma (HCC)).] |
|
ORM-13070 C-11
|
DB15324 |
[ORM-13070 C-11 is under investigation in clinical trial NCT00735774 (Suitability of 11C-ORM-13070 as a PET Tracer).] |
|
Trelagliptin
|
DB15323 |
[Trelagliptin is under investigation in clinical trial NCT03555591 (Specified Drug-Use Survey of Trelagliptin Tablets "Survey on Long-term Use in Patients With Type 2 Diabetes Mellitus").] |
